Meier Ute-Christiane, Ramagopalan Sreeram V, Goldacre Michael J, Goldacre Raph
Blizard Institute, Queen Mary University of London, London, United Kingdom.
Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, United Kingdom.
Front Psychiatry. 2020 Jul 16;11:662. doi: 10.3389/fpsyt.2020.00662. eCollection 2020.
The epidemiology of psychiatric comorbidity in multiple sclerosis (MS) remains poorly understood.
We aimed to determine the risk of schizophrenia and bipolar disorder in MS patients.
Retrospective cohort analyses were performed using an all-England national linked Hospital Episode Statistics (HES) dataset (1999-2016) and to determine whether schizophrenia or bipolar disorder are more commonly diagnosed subsequently in people with MS (n=128,194), and whether MS is more commonly diagnosed subsequently in people with schizophrenia (n=384,188) or bipolar disorder (n=203,592), than would be expected when compared with a reference cohort (~15 million people) after adjusting for age and other factors. Adjusted hazard ratios (aHRs) were calculated using Cox proportional hazards models.
Findings were dependent on whether the index and subsequent diagnoses were selected as the primary reason for hospital admission or were taken from anywhere on the hospital record. When searching for diagnoses anywhere on the hospital record, there was a significantly elevated risk of subsequent schizophrenia (aHR 1.51, 95% confidence interval (CI) 1.40 to 1.60) and of bipolar disorder (aHR 1.14, 95% CI 1.04 to 1.24) in people with prior-recorded MS and of subsequent MS in people with prior-recorded schizophrenia (aHR 1.26, 1.15-1.37) or bipolar disorder (aHR 1.73, 1.57-1.91), but most of these associations were reduced to null when analyses were confined to diagnoses recorded as the primary reason for admission.
Further research is needed to investigate the potential association between MS and schizophrenia and/or bipolar disorder as it may shed light on underlying pathophysiology and help identify potential shared risk factors.
多发性硬化症(MS)中心理疾病共病的流行病学情况仍了解不足。
我们旨在确定MS患者患精神分裂症和双相情感障碍的风险。
使用全英格兰全国性关联医院事件统计(HES)数据集(1999 - 2016年)进行回顾性队列分析,以确定精神分裂症或双相情感障碍在MS患者(n = 128,194)中随后被诊断出的情况是否更常见,以及在精神分裂症患者(n = 384,188)或双相情感障碍患者(n = 203,592)中随后被诊断出MS的情况是否比在调整年龄和其他因素后与参考队列(约1500万人)相比时预期的更常见。使用Cox比例风险模型计算调整后的风险比(aHRs)。
研究结果取决于索引诊断和后续诊断是被选为住院的主要原因还是取自医院记录的任何地方。当在医院记录的任何地方搜索诊断时,既往有MS记录的患者随后患精神分裂症的风险显著升高(aHR 1.51,95%置信区间(CI)1.40至1.60)和患双相情感障碍的风险(aHR 1.14,95%CI 1.04至1.24),既往有精神分裂症记录的患者随后患MS的风险(aHR 1.26,1.15 - 1.37)或既往有双相情感障碍记录的患者随后患MS的风险(aHR 1.73,1.57 - 1.91),但当分析仅限于记录为入院主要原因的诊断时,这些关联大多减弱至无统计学意义。
需要进一步研究来调查MS与精神分裂症和/或双相情感障碍之间的潜在关联,因为这可能有助于揭示潜在的病理生理学机制并有助于识别潜在的共同风险因素。